hexamethonium has been researched along with Trigeminal Autonomic Cephalalgias in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Trigeminal Autonomic Cephalalgias: Primary headache disorders that show symptoms caused by the activation of the AUTONOMIC NERVOUS SYSTEM of the TRIGEMINAL NERVE. These autonomic features include redness and tearing of the EYE, nasal congestion or discharge, facial SWEATING and other symptoms. Most subgroups show unilateral cranial PAIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trigeminal autonomic cephalalgias are highly disabling primary headache disorders, characterized by severe unilateral head pain and associated ipsilateral cranial autonomic features." | 1.38 | A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization. ( Akerman, S; Goadsby, PJ; Holland, PR; Lasalandra, MP; Summ, O, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akerman, S | 1 |
| Holland, PR | 1 |
| Summ, O | 1 |
| Lasalandra, MP | 1 |
| Goadsby, PJ | 1 |
1 other study available for hexamethonium and Trigeminal Autonomic Cephalalgias
| Article | Year |
|---|---|
A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization.
Topics: Action Potentials; Analysis of Variance; Animals; Disease Models, Animal; Electric Stimulation; Elec | 2012 |